The effects of hormone resuscitation on cardiac function and hemodynamics in a porcine brain-dead organ donor model

American Journal of Transplantation

Volumn 7, Issue 4, 2007, Pages 809-817

  Hing, A J ^a,b   Hicks, M ^a,b   Garlick, S R ^b   Gao, L ^a   Kesteven, S H ^a   Faddy, S C ^b   Wilson, M K ^b   Feneley, M P ^a,b   MacDonald, P S ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Catecholamines; Contractility; Donor management; Hemodynamics; Hormones; Resuscitation; Tissue donors; Transplantation

Indexed keywords

INSULIN; LIOTHYRONINE; METHYLPREDNISOLONE; NORADRENALIN; VASOPRESSIN;

ADD ON THERAPY; ANIMAL EXPERIMENT; ARTICLE; BRAIN DEATH; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG EFFECT; DRUG EFFICACY; FLUID THERAPY; GRAFT DYSFUNCTION; HEART FUNCTION; HEART GRAFT; HEART HEMODYNAMICS; HEART MUSCLE CONTRACTILITY; HEART OUTPUT; HEART STROKE VOLUME; HEART TRANSPLANTATION; LOW DRUG DOSE; MEAN ARTERIAL PRESSURE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RESUSCITATION; SWINE;

ANIMALS; BRAIN DEATH; HEART; HORMONES; INSULIN; METHYLPREDNISOLONE; MODELS, ANIMAL; NOREPINEPHRINE; RESUSCITATION; SWINE; TISSUE DONORS; TRIIODOTHYRONINE; VASOPRESSINS;

EID: 33947588985     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01735.x     Document Type: Article

References (57)

1. Copeland JG. Advanced medical therapy does not render heart transplantation obsolete for ambulatory end-stage heart failure patients: A debate. J Heart Lung Transplant 2001; 20: 725-728.
2. Conte JV, Fleischer KJ, Baumgartner WA. Evaluation and management of heart donors. In: Baumgartner WA, Kasper E, Reitz B, Theodore J, (eds). Heart and Lung Transplantation. 2nd Ed. Philadelphia: W.B. Saunders Company, 2002; 155-160.
3. Zaroff JG, Rosengard BR, Armstrong WF et al. Consensus conference report: Maximizing use of organs recovered from the cadaver donor: Cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: 836-841.
4. Excell L, Russ G, Wride P (eds). ANZOD Registry Report 2006. Adelaide: Australia and New Zealand Organ Donation Registry, 2006.
5. Rosendale JD, Chabalewski FL, McBride MA et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2: 761-768.
6. Hicks M, Hing A, Gao L, Ryan J, Macdonald PS. Organ Preservation. In: Hornick P, Rose M (eds). Transplantation Immunology: Methods and Protocols. Totowa: Humana Press Inc., 2006: 331-373.
7. Pratschke J, Wilhelm MJ, Kusaka M et al. Brain death and its influence on donor organ quality and outcome after transplantation. Transplantation 1999; 67: 343-348.
8. Novitzky D, Wicomb WN, Cooper DK, Rose AG, Fraser RC, Barnard CN. Electrocardiographic, hemodynamic & endocrine changes occurring during experimental brain death in the chacma baboon. J Heart Transplant 1984; IV: 63-69.
9. Novitzky D. Detrimental effects of brain death on the potential organ donor. Transplantation Proceedings 1997; 29: 3770-3772.
10. Seguin C, Devaux Y, Grosjean S et al. Evidence of functional myocardial ischemia associated with myocardial dysfunction in brain-dead pigs. Circulation 2001; 104(12 Suppl 1): I197-I201.
11. Wilhelm MJ, Pratschke J, Laskowski IA, Paz DM, Tilney NL. Brain death and its impact on the donor heart-lessons from animal models. J Heart Lung Transplant 2000; 19: 414-418.
12. Mertes PM, el Abassi K, Jaboin Y et al. Changes in hemodynamic and metabolic parameters following induced brain death in the pig. Transplantation 1994; 58: 414-418.
13. Smith M. Physiologic changes during brain stem death-lessons for management of the organ donor. J Heart Lung Transplant 2004; 23(9 Suppl): s217-s222.
14. Pennefather SH, Bullock RE, Mantle D, Dark JH. Use of low dose arginine vasopressin to support brain-dead organ donors. Transplantation 1995; 59: 58-62.
15. Powner DJ, Hendrich A, Nyhuis A, Strate R. Changes in serum catecholamine levels in patients who are brain dead. J Heart & Lung Transplant 1992; 11: 1046-1053.
16. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation 1988; 45: 32-36.
17. Shivalkar B, Van Loon J, Wieland W et al. Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation 1993; 87: 230-239.
18. Novitzky D, Cooper DK, Morrell D, Isaacs S. Brain death, triiodothyronine depletion, and inhibition of oxidative phosphorylation: Relevance to management of organ donors. Transplantation Proceedings 1987; 19: 4110-4111.
19. Gifford RR, Weaver AS, Burg JE, Romano PJ, Demers LM, Pennock JL. Thyroid hormone levels in heart and kidney cadaver donors. J Heart Transplant 1986; 5: 249-253.
20. Chen JM, Cullinane S, Spanier TB et al. Vasopressin deficiency and pressor hypersensitivity in hemodynamically unstable organ donors. Circulation 1999; 100(19 Suppl): II244-II246.
21. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43: 852-854.
22. Wilhelm MJ, Pratschke J, Beato F et al. Activation of the heart by donor brain death accelerates acute rejection after transplantation. Circulation 2000; 102: 2426-2433.
23. Pratschke J, Kofla G, Wilhelm MJ et al. Improvements in early behavior of rat kidney allografts after treatment of the brain-dead donor. Ann Surg 2001; 234: 732-740.
24. Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation 1998; 65: 1533-1542.
25. Plenz G, Eschert H, Erren M et al. The interleukin-6/interleukin-6- receptor system is activated in donor hearts. J Am College Cardiol 2002; 39: 1508-1512.
26. Amado JA, Lopez-Espadas F, Vazquez-Barquero A et al. Blood levels of cytokines in brain-dead patients: Relationship with circulating hormones and acute-phase reactants. Metabolism: Clin Exp 1995; 44: 812-816.
27. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17: 423-429.
28. Wheeldon DR, Potter CD, Oduro A, Wallwork J, Large SR. Transforming the "unacceptable" donor: Outcomes from the adoption of a standardized donor management technique. J Heart Lung Transplant 1995; 14: 734-742.
29. Rosengard BR, Feng S, Alfrey EJ et al. Report of the Crystal City meeting to maximize the use of organs recovered from the cadaver donor. Am J Transplant 2002; 2: 701-711.
30. Ryan JB, Hicks M, Cropper JR et al. The preload recruitable stroke work relationship as ameasure of left ventricular contractile dysfunction in porcine cardiac allografts. Euro J Cardio-Thoracic Surgery 2002; 22: 738-745.
31. NHMRC. Australian Code of Practice for the Care and Use of Animals for Scientific Purpose. 7th Ed. Canberra: Australian Government, 2004.
32. Glower DD, Spratt JA, Snow ND et al. Linearity of the Frank-Starling relationship in the intact heart: The concept of preload recruitable stroke work. Circulation 1985; 71: 994-1009.
33. Schnuelle P, Berger S, de Boer J, Persijn G, van der Woude FJ. Effects of catecholamine application to brain-dead donors on graft survival in solid organ transplantation. Transplantation 2001; 72: 455-463.
34. Movahed A, Reeves WC, Mehta PM, Gilliland MG, Mozingo SL, Jolly SR. Norepinephrine-induced left ventricular dysfunction in anesthetized and conscious, sedated dogs. Int J Cardiol 1994; 45: 23-33.
35. Todd GL, Baroldi G, Pieper GM, Clayton FC, Eliot RS. Experimental catecholamine-induced myocardial necrosis. I. Morphology, quantification and regional distribution of acute contraction band lesions. J Mol Cellular Cardiol 1985; 17: 317-338.
36. Bittner HB, Chen EP, Craig D, Van Trigt P. Preload-recruitable stroke work relationships and diastolic dysfunction in the braindead organ donor. Circulation 1996; 94(9 Suppl): II320-II325.
37. Lyons JM, Pearl JM, McLean KM et al. Glucocorticoid administration reduces cardiac dysfunction after brain death in pigs. J Heart Lung Transplant 2005; 24: 2249-2254.
38. Ryan JB, Hicks M, Cropper JR et al. Functional evidence of reversible ischaemic injury immediately after sympathetic storm associated with experimental brain death. J Heart Lung Transplant 2003; 22: 922-928.
39. White M, Wiechmann RJ, Roden RL et al. Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage. Circulation 1995; 92: 2183-2189.
40. Bittner HB, Kendall SW, Chen EP, Van Trigt P. The combined effects of brain death and cardiac graft preservation on cardiopulmonary hemodynamics and function before and after subsequent heart transplantation. J Heart Lung Transplant 1996; 15: 764-777.
41. Snow TR, Deal MT, Connelly TS, Yokoyama Y, Novitzky D. Acute inotropic response of rabbit papillary muscle to triiodothyronine. Cardiology 1992; 80: 112-117.
42. Ririe DG, Butterworth JFt, Royster RL, MacGregor DA, Zaloga GP. Triiodothyronine increases contractility independent of beta-adrenergic receptors or stimulation of cyclic-3′,5′-adenosine monophosphate. Anesthesiology 1995; 82: 1004-1012.
43. Jamall IN, Pagel PS, Hettrick DA et al. Positive inotropic and lusitropic effects of triiodothyronine in conscious dogs with pacing-induced cardiomyopathy. Anesthesiology 1997; 87: 102-109.
44. Holt E, Sjaastad I, Lunde PK, Christensen G, Sejersted OM. Thyroid hormone control of contraction and the Ca(2+)-ATPase/ phospholamban complex in adult rat ventricular myocytes. J Mol Cellular Cardiol 1999; 31: 645-656.
45. Sayen MR, Rohrer DK, Dillmann WH. Thyroid hormone response of slow and fast sarcoplasmic reticulum Ca2+ ATPase mRNA in striated muscle. Mol Cellular Endocrinol 1992; 87: 87-93.
46. Trivieri MG, Oudit GY, Sah R et al. Cardiac-specific elevations in thyroid hormone enhance contractility and prevent pressure overload-induced cardiac dysfunction. Proc Nat Acad Sc USA 2006; 103: 6043-6048.
47. D'Amico TA, Meyers CH, Koutlas TC et al. Desensitization of myocardial beta-adrenergic receptors and deterioration of left ventricular function after brain death. J Thoracic Cardio Surgery 1995; 110: 746-751.
48. Cruickshank JM, Neil-Dwyer G, Degaute JP et al. Reduction of stress/catecholamine-induced cardiac necrosis by beta 1-selective blockade. Lancet 1987; 2: 585-589.
49. Chiari P, Hadour G, Michel P et al. Biphasic response after brain death induction: Prominent part of catecholamines release in this phenomenon. J Heart Lung Transplant 2000; 19: 675-682.
50. Hing A, Hicks M, Gao L et al. Hormone resuscitation of the brain dead donor and its effects on transplantable organs. Transplantation 2006; 82(Suppl 3 WTC Abstracts): 439.
51. Carrier O Jr., Wedell EK, Barron KW. Specific alpha-adrenergic receptor desensitization in vascular smooth muscle. Blood Vessels 1978; 15: 247-258.
52. Chen EP, Bittner HB, Kendall SW, Van Trigt P. Hormonal and hemodynamic changes in a validated animal model of brain death. Crit Care Med 1996; 24: 1352-1359.
53. Wan S, DeSmet JM, Antoine M, Goldman M, Vincent JL, LeClerc JL. Steroid administration in heart and heart-lung transplantation: Is the timing adequate? Ann Thoracic Surg 1996; 61: 674-678.
54. Busuttil RW, George WJ, Hewitt RL. Protective effect of methylprednisolone on the heart during ischemic arrest. J Thoracic Cardio Surgery 1975; 70: 955-965.
55. Rosendale JD, Kauffman HM, McBride MA et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 2003; 75: 1336-1341.
56. Rosendale JD, Kauffman HM, McBride MA et al. Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 2003; 75: 482-487.
57. Rosendale JD, Kauffman HM, McBride MA et al. Hormonal resuscitation associated with more transplanted organs with no sacrifice in survival. Transplantation 2004; 78(2, Supplement 1): 17.